Podcasts about nih

Lay of The Land's conversation today is with Afif Ghannoum, a biotech attorney by background and the CEO of BIOHM Health — which he co-founded with his father, Dr. Mahmoud Ghannoum, a leading microbiome researcher and recognized for naming the mycobiome (the body's fungal community). With over 30,000 citations and 500 published papers, Dr. Ghannoum is one of the top 0.5% of cited microbiologists and the top 2% of all scientists across all disciplines and has been continuously funded by the National Institutes of Health (NIH) since 1991, including just receiving his latest NIH grant at age 72.Leveraging his own background launching and selling consumer products in over 27,000 stores and licensed IP to companies around the world in addition to holding several biotech patents, Afif partnered with his dad to commercialize his research and science into world-class consumer products through their company, BIOHM Health.With state-of-the-art science and one of the largest microbiome datasets in the world that combines bacterial and fungal sequencing, BIOHM was the first to address the critical link between fungi and bacteria in gut health. Over the last year, BIOHM has expanded its role with some of the largest global ingredient companies to offer a world-class suite of services, including product development leveraging its industry-leading database, bioinformatics, testing, and clinical trial support — their first BIOHM FX probiotic supplement was designed to specifically help reduce digestive plaque found in the gut.BIOHM is currently embarking on a clinical extension directly for medical practitioners and is quickly expanding into retailers across the country, as it not only manages one of the most comprehensive gut health datasets, but also has access to one of the largest collections of fungi strains, second only to the Centers for Disease Control and Prevention (CDC).In late 2022, Afif secured $7.5 million in funding for BIOHM to support their broader vision. BIOHM is a fascinating company based here in Cleveland and I loved learning more about Afif's journey building it — please enjoy my conversation with Afif Ghannoum--Connect with Afif Ghannoum on LinkedIn — https://www.linkedin.com/in/afifghannoum/Follow Afif Ghannoum on Twitter @AfifGhannoum — https://twitter.com/AfifGhannoumLearn more about BIOHM Health — https://www.biohmhealth.com/Follow BIOHM Health on Twitter @biohmhealth — https://twitter.com/biohmhealth--Connect with Jeffrey Stern on LinkedIn — https://www.linkedin.com/in/jeffreypstern/Follow Jeffrey Stern on Twitter @sternJefe — https://twitter.com/sternjefeFollow Lay of The Land on Twitter @podlayofthelandhttps://www.jeffreys.page/

Do you ever wonder why some runners are better at shorter distances while others are far more suited to longer distances?   Well, a lot of this has to do with the type of muscle fibers you're predisposed to having.   But, what many runners don't know is that there are ways to train to specifically target certain muscle fiber types and thus improve our weaknesses.   In today's episode, Coach Andie is going to take an in-depth look at muscle fibers to better understand how they influence your training.   You'll learn what the different muscle fiber types are and what they do and how to specifically target each in your training.   Now, don't worry, you don't need a science degree to follow along, she'll keep it simple. Connect, Comment, Community Follow RunnersConnect on Instagram Join the Elite Treatment where you get first dibs on everything RTTT each month! Runners Connect Winner's Circle Facebook Community  RunnersConnect Facebook page GET EXPERT COACHING AT RUNNERSCONNECT! This week's show brought to you by: Delta G Ketones have been one of the most well-researched chemicals when it comes to endurance performance. Their only downside is that it typically takes 2 days of fasting for your body to produce them in quantities that would help your performance But, thanks to deltaG and collaborations from the US Military and researchers from NIH and the University of Oxford, they've developed a ketone drink that can boost your ketone levels to those seen after 2 days of fasting in just 20 minutes.  The academic literature on the effectiveness of ketones for running performance is overwhelming. If you want to see more of the research, head to runnersconnect.net/deltag Plus, use the code RTT20 when you do and you can save 20% on any purchase you make. Mobility Wall We all know how important foam rolling is for staying injury-free and just plain feeling better for every run. But, let's face it, many of us skip it because clearing out space on the floor feels like too much work, the pressure is too painful and difficult to control, or you can't seem to hit the right spots. That's why I was so amazed when I saw the door-mounted foam roller from Mobility Wall.  The Mobility Wall device mounts to your doorframe in just a few seconds and is easy to move up and down the frame in just a few seconds.  Not only does this get you off the ground and ready to foam roll in just a few seconds, it also allows you to easily hit muscles in your neck and shoulders that aren't possible with a traditional foam roller.  Even better, because you're off the ground, you don't have to control gravity to adjust the pressure. You simply use upward and inward pressure, which is much easier to control. The days of painful foam rolling are over.  If you've been wanting to get more consistent with your injury-prevention work this year, the Mobility Wall foam roller will be a game changer. I can't believe how much more I've been foam rolling since I started using it.  Plus, we've got a special offer for you. Just go to mobilitywall.com/RTTT or enter RTTT at checkout for 20% off your first order. Plus, it comes with a free app that gives you video instructions on exactly how to hit every area.

Our guest for this episode is Erin Sharoni, who is a Master of Bioethics degree candidate (‘23) at Harvard Medical School and a seasoned biotechnology executive with expertise in longevity, epigenetics, and Artificial Intelligence (AI). We discussed the incredibly important value of ethics in the field of AI, and explored the reasons why at this most pivotal of times in human history, there hasn't been enough conversations around this subject.  Erin has over 15 years of experience building products and brands in molecular health, media, and finance. She has held roles at top financial institutions like Bridgewater Associates, biotech startups like InsideTracker, and worked as an anchor and commentator on national television. Erin sits on the Advisory Board of Animal Save Movement, a global animal rights organization that aims to end animal exploitation through the act of bearing witness and through her work, is passionate about developing animal-free research technologies. Erin holds an additional master's degree in the field of Biology from Harvard, and a BA with Honors in Studio Art from Wesleyan University. She is currently a researcher for the NIH's AI program, Bridge2AI, where she focuses on the ethics of AI in three-dimensional cell mapping for disease prediction. Instagram https://www.instagram.com/erinsharoni/ LinkedIn https://www.linkedin.com/in/erinsharoni/ Twitter https://twitter.com/erinsharoni   Follow us: Join the NEURO Academy: https://neuroacademy.com/ Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: https://thebraindocs.com/

This week we sit down with Maria Vazquez Roque, MD, MSc to discuss screening for colon cancer and cancer disparities in the hispanic population in recognition of Colorectal Cancer Awareness Month.Dr. Vazquez Roque is from San Juan, Puerto Rico. In 2003, she completed her medical degree at the University of Puerto Rico Medical Sciences Campus. In 2008 she finished her internal medicine residency in Puerto Rico. She then pursued a Gastroenterology fellowship in the NIH training grant at Mayo Clinic Rochester, Minnesota. After graduating from GI fellowship, she began to work in the Division of Gastroenterology and Hepatology at Mayo Clinic Florida in April 2012. She is currently an Associate Professor in the Department of Medicine, the Associate Chair for the Outpatient Practice for the Department of Medicine, and Medical Director for Accreditation and Supply Chain for Mayo Clinic Florida. She championed and developed the Fecal Microbiota Transplant program at the Mayo Clinic Florida campus for patients who suffer from recurrent episodes of Clostridium difficile infection and to date has conducted over 200 procedures with success. She is actively participating in research studies evaluating the role of the gut microbiome in immunotherapy and immune checkpoint inhibitor colitis.

Join Dr. Jeffrey Gladden, Steve Reiter and Dr. Paul Harch in this episode of the Gladden Longevity podcast. Paul G. Harch, M.D. is a clinical private practice and academic physician who made a discovery in 1989 treating divers with chronic brain decompression illness.  He found that the wounds in these divers' brains were similar to chronic extremity wounds, but they were only responsive to a non-traditional dose of hyperbaric oxygen therapy. In 2004, based on the life-extending outcomes of treating patients with dementia, he proposed the longevity potential of HBOT to the American Academy of Anti-Aging Medicine.  In March 2020, he proved the efficacy of HBOT in mild TBI persistent post-concussion syndrome in a randomized controlled trial and proposed HBOT application to COVID. Now in its 3rd edition, HBOT is explained as an epigenetic therapy with expected revolutionary effects on medicine, neurology, and longevity. In this episode, they talk about HBOT as a dual-component drug, the primary target of HBOT, and how HBOT is a treatment for wounds and inflammatory conditions in any location and of any duration. Do you know the medical benefits of HBOT? Listen to find out more.  Listen to this episode to learn about making a 100 the new 30, and living beyond 120!    Dr. Gladden considers Dr. Harch to be one of the fathers or grandfathers of hyperbaric oxygen therapy (00:58).  Dr. Harch explains what drew him into researching hyperbaric oxygen therapy. (1:35)  Dr. Harch discusses why hyperbaric oxygen therapy is used for scuba divers or diving medicine. (3:05)  Dr. Harch mentions how important the first hour is when using hyperbaric oxygen to treat injuries divers may have. (6:05)  Dr. Gladden shares that molecular hydrogen is a way to modulate reperfusion injury. (7:00)  Dr. Harch notes that if you can give the hyperbaric treatment in the first hour, it totally inhibits those attachment molecules on the white blood cells from expressing themselves. (9:45)  Dr. Harch says all coastal facilities that treat divers do not get the same results the US Navy does. (11:15)  Dr. Gladden infers that everything is in its own balance. (13:10)  Dr. Harch clarifies that barometric pressure is a separate entity from oxygen. (15:14)  Dr. Harch mentions that only a few people have used dosing as a primary method of treatment. (18:15)  Dr. Harch elaborates on hypoxia-inducing factors. (21:44)  Dr. Harch says there is a whole literature now on hyperbaric oxygen preconditioning. (23:08)  Dr. Harch expresses that if you give two hyperbaric treatments a night before cardiac surgery, you significantly reduce the cognitive insult that results after surgery. (25:40)  Focuscalm.com uses the promo code longevity10 to get a 10 percent discount. (28:55)  Dr. Harch argues that doctors are trained and taught reimbursable medicine. (30:17)  Dr.  Harch discloses that so much of brain diseases are caused by problems in the white matter. (33:07)  Dr. Harch reveals his treatment approach. (36:45)  Dr. Harch specifies that he has treated 130 drowned children over the years. (39:50)  Dr. Harch recounts his interaction with the FDA some time back. (43:23)  Dr. Harch gives reasons why people may not benefit from hyperbaric chambers. (46:33)  Dr. Gladden points out how inflammation becomes a problem as people get older. (49:15)  Dr. Harch recalls going to the NIH and FDA to seek funding for studies. (52:25)  Dr. Harch testifies that he has treated many dementia patients and shares that hyperbaric treatment prolongs their lives. (57:05)  Dr. Harch confesses that hyperbaric oxygen has limited or no effect on ALS by itself. (59:08)          Visit our website, www.gladdenlongevitypodcast.com, for more information on this episode and other episodes as well. Click on the link to let us know what you'd like us to talk about on the podcast too!          Follow us on social media!                    Instagram: @gladdenlongevity                    Twitter: @gladdenlongevit                    Facebook: @GladdenLongevity             LinkedIn: @GladdenLongevity     For more information on our practice or how to become a client, visit:   www.gladdenlongevity.com   Call us: 972-310-8916  Or email us: info@gladdenlongevity.com    To learn more about Dr. Paul Harch's work check out the following:   Website: www.HBOT.com,  Email:  hbot@hbot.com  Phone number: 504-309-4948    Discount code:   Longevity10 (for 10% off your purchase at the Gladden Longevity Supplement shop https://gladdenlongevityshop.com/) 

Synopsis: Joel Schneider, Ph.D. and Robert Kotin, Ph.D. are the President & CEO and Founder & Chief Technology Advisor, respectively, of Carbon Biosciences, an emerging leader in the development of novel parvovirus-derived gene therapies. Joel and Robert sit down with host Rahul Chaturvedi to discuss the arc of their careers, how the AAV field has changed over the last decade, and how they approach building out their team at Carbon. They also talk about Carbon's focus on cystic fibrosis and the implications of The Cystic Fibrosis Foundation investing in their Series A. Finally, they both weigh in on what excites them when thinking about the future of gene therapy. Biographies: Dr. Joel Schneider joined Carbon as CEO in 2022, after serving as Chief Operating Officer at Solid Biosciences. As Solid's first employee, he played an instrumental role in building the company's unique disease-focused business model. Dr. Schneider is an accomplished biosciences executive with a track record of achievement in identifying, developing, and financing high potential therapeutic modalities and has diverse leadership experiences across R&D, technical and corporate operations, and corporate development organizations. Dr. Schneider holds a Ph.D. from Rutgers University and an undergraduate degree from Brandeis University and is the author of numerous peer-reviewed articles related to Duchenne and stem cell biology. He completed a postdoctoral fellowship at Harvard University in the Department of Stem Cell and Regenerative Biology, where he characterized and developed the small molecules that enhance skeletal muscle regeneration. Dr. Robert Kotin has been a leader in adeno-associated virus (AAV) research for 35 years, focusing on the molecular biology of the virus's non-structural proteins and then leveraging this understanding to develop novel AAV vectors for somatic cell gene therapy. Beginning as a postdoctoral fellow at Cornell University Medical Center, Dr. Kotin discovered a common integration site for AAV DNA in human chromosome 19, which he designated AAVS1 locus. He spent most of his career in the Intramural Research Program at the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), first as a tenure-track investigator and then as a tenured senior investigator and Head of the Laboratory of Molecular Biology and Gene Therapy. While at the NIH, Dr. Kotin's laboratory invented and developed a scalable recombinant adeno-associated virus (rAAV) production process in Sf9 cells which was licensed by UniQure, ThermoFisher, Voyager, Biomarin, and others and was used to produce Glybera™, the first rAAV product granted regulatory agency approval for sale. Additional research from the Kotin lab resulted in the discovery of an AAV replicative product that has been described as closed-ended linear duplex DNA (ceDNA) and became the basis of the non-viral gene therapy company Generation Bio (NASDAQ: GBIO). Dr. Kotin served as vice president of virology and gene therapy at Voyager Therapeutics from 2014 to 2016. Since 2016, he has served as an adjunct professor at UMass Medical School, where his research interests include vectorizing and characterizing ancestral parvoviruses based on inferred sequences from endogenous virus elements (EVEs) as novel gene therapy vectors. Dr. Kotin earned his B.A. in biology from the University of California, Santa Cruz, and his doctorate in microbiology from Rutgers University and the University of Medicine and Dentistry of New Jersey (now Robert Wood Johnson Medical School).

In this episode of “Intention to Treat,” some of the people who have worked closely with “America's Doctor,” Anthony Fauci, offer insights into his character, values, accomplishments, and adventures over his decades of service at the NIH. . The Fauci Phenomenon. N Engl J Med 2023;388:e28.

The following question refers to Section 8.1 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.  The question is asked by Western Michigan University medical student & CardioNerds Intern Shivani Reddy, answered first by Brigham & Women's medicine resident and Director of CardioNerds Internship Dr. Gurleen Kaur, and then by expert faculty Dr. Prateeti Khazanie. Dr. Khazanie is an Associate Professor and Advanced Heart Failure and Transplant Cardiologist at the University of Colorado. She was an undergraduate at Duke University as a B.N. Duke Scholar. She spent two years at the NIH in the lab of Dr. Anthony Fauci and completed a dual MD-MPH program at Duke Medical School. When she started residency, she thought she was going to be an ID doctor, but she fell in love with cardiology at Stanford where she was an intern, resident, and then chief resident. She went back to Duke for her general cardiology and advanced heart failure/transplant fellowships as well as research training at the DCRI. Dr. Khazanie joined the University of Colorado in 2015 as a health services clinician researcher with a focus on improving health equity and bioethics in advanced heart failure care. She mentors medical students, residents, and fellows and is a faculty mentor for the University of Colorado Cardiology Fellows “House of Cards” mentoring group. She has research funding from the NIH/NHLBI K23, NIH Ethics Grant, and Ludeman Center for Women's Health Research. Dr. Khazanie is an author on the 2022 ACC/AHA/HFSA HF Guidelines, the 2021 HFSA Universal Definition of Heart Failure, and multiple scientific statements. The Decipher the Guidelines: 2022 AHA / ACC / HFSA Guideline for The Management of Heart Failure series was developed by the CardioNerds and created in collaboration with the American Heart Association and the Heart Failure Society of America. It was created by 30 trainees spanning college through advanced fellowship under the leadership of CardioNerds Cofounders Dr. Amit Goyal and Dr. Dan Ambinder, with mentorship from Dr. Anu Lala, Dr. Robert Mentz, and Dr. Nancy Sweitzer. We thank Dr. Judy Bezanson and Dr. Elliott Antman for tremendous guidance. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. Question #11 A 64-year-old woman with a history of chronic systolic heart failure secondary to NICM (LVEF 15-20%) s/p dual chamber ICD presents for routine follow-up. She reports several months of progressive fatigue, dyspnea, and peripheral edema. She has been hospitalized twice in the past year with acute decompensated heart failure. Efforts to optimize guideline directed medical therapy have been tempered by episodes of lightheadedness and hypotension. Her exam is notable for an elevated JVP, an S3 heart sound, and a III/VI holosystolic murmur best heard at the apex with radiation to the axilla. Labs show Na 130 mmol/L, Cr 1.8 mg/dL (from 1.1 mg/dL 6 months prior), and NT-proBNP 1,200 pg/mL. ECG in clinic shows sinus rhythm and a nonspecific IVCD with QRS 116 ms. Her most recent TTE shows biventricular dilation with LVEF 15-20%, moderate functional MR, moderate functional TR and estimated RVSP of 40mmHg. What is the most appropriate next step in management? A Refer to electrophysiology for upgrade to CRT-D B Increase sacubitril-valsartan dose C Refer for advanced therapies evaluation D Start treatment with milrinone infusion Answer #11 Explanation The correct answer is C – refer for advanced therapies evaluation. Our patient has multiple signs and symptoms of advanced heart failure including NYHA Class III-IV functional status, persistently elevated natriuretic peptides, severely reduced LVEF, evidence of end organ dysfunction, multiple hospitalizations for ADHF, edema despite escalating doses of diuretics, and progressive intolerance to GDMT. Importantly, the 2018 European Society of Cardiology revised definition of advanced HF focuses...

In this episode, host Dr. Aaron Fritts interviews FLOW Medical cofounders Dr. Osman Ahmed and Dr. Jonathan Paul about how they built a company with the goal of designing a data-driven thrombolytic device that can deliver personalized care for patients with pulmonary embolism. --- CHECK OUT OUR SPONSOR RapidAI http://rapidai.com/?utm_campaign=Evergreen&utm_source=Online&utm_medium=podcast&utm_term=Backtable&utm_content=Sponsor --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/KikSeM --- SHOW NOTES Dr. Paul, interventional cardiologist, begins by explaining how he and Dr. Ahmed, interventional radiologist, came to work together. Dr. Ahmed came to the University of Chicago shortly after Dr. Paul started a pulmonary embolism response team (PERT) program. Dr. Ahmed, through his IR training, had experience with PE/VTE. They met and decided to combine their knowledge to build the program together. They both saw a need for new catheter directed thrombolytic (CDT) devices in their respective fields. The landscape of thrombectomy device innovation was booming, but they did not see the same innovation happening for CDT. After they both received the COVID vaccine, they were eating at Panera and drew out the idea for their device on a napkin. Neither of them had prior engineering experience and didn't know how to proceed after this, so they relied on the University of Chicago's entrepreneurial programs as a starting place. They then did market research and used their own internal research funding to subcontract with an engineering firm. They have been working on the design prototype since, and are conducting animal studies to trial the device. Once they reach design freeze, they will start the regulatory process and NIH 510(k) submission. They also have an NIH SBIR grant for small businesses doing innovative research. They plan to have the device on market in mid 2024. The goal for their device is to make it a catheter that can provide real-time feedback to minimize the complications of both too little or too much thrombolytic therapy. They are installing a sensor on the device that displays how much of the clot is lysed and allows for personalized PE treatment. They hope to incorporate AI into their data management, which they will use to tailor treatment in future patients. --- RESOURCES FLOW Medical: https://www.flowmedical.co

Katherine is chief of Science Advancement and Outreach (SAO) at PETA (People for the Ethical Treatment of Animals). SAO aims to change the paradigm of biomedical research by promoting the development & implementation of cutting-edge strategies in biomedical research & training & eliminating the use of animals in experimentation. Katherine earned her bachelor's degrees in biology psychology from Syracuse University and her Ph.D. in experimental psychology and cognitive science from the University of California–San Diego. After completing a postdoctoral fellowship at Johns Hopkins University, she went on to become a research fellow at the National Institute of Mental Health, where she stayed for eight years. Over the course of her research career, she studied the neural correlates of linguistic, spatial, & memory processes, working with children with early focal brain injury, adults & children with schizophrenia, and individuals with Williams syndrome and related genetic disorders. Katherine has more than 20 years of experience conducting brain and neuroimaging research with humans and is an expert at experimental design and data analysis. She has been published in numerous peer-reviewed journals and has presented her findings at national and international industry conferences. In Sentientist Conversations we talk about the two most important questions: “what's real?” & “who matters?” Sentientism is "evidence, reason & compassion for all sentient beings." The video of our conversation is here on YouTube. We discuss: 00:00 Welcome 01:29 Katherine's Intro - from neuroscience and the NIH to PETA - "About half of biomedical research... involves very invasive procedures with animals" - "It became clear to me that that assumption... that the harms we were doing were justifiable... fell apart... the harms were much greater than I realised but also... there's a lot of species differences that make data from these labs difficult to translate into benefits for humans." - "Then the question becomes... well what are we doing?" - "Trying to make sure people realise how sentient these animals really are... they have their own needs & wants & desires" - Previous episodes with Ingrid Newkirk https://youtu.be/M7Ac2Ba2jbM & Aysha Akhtar https://youtu.be/EZ_gh0ldzpo 04:55 What's Real? - "Religious but not deeply religious" parents - Anglican, episcopalian Christians - "It never really took" - Not needing external reasons for "wanting to cause as little harm as possible and to live in harmony with the world around us" - Learning about animals through science "started to change the way I viewed them" 24:54 What & Who Matters? 46:49 How Can We Make a Better Future? ...and much more. Full show notes at Sentientism.info. Sentientism is “Evidence, reason & compassion for all sentient beings.” More at Sentientism.info. Join our "I'm a Sentientist" wall via this simple form. Everyone, Sentientist or not, is welcome in our groups. The biggest so far is here on FaceBook. Come join us there!

As more comes out of Congressional hearings and documents that purports to show the origins of Covid-19, Americans are wondering if we are starting to get real answers. Megan Basham, Daily Wire and an investigative journalist, joins to discuss. She traced some of the narratives around the vax back to their origins and how church leaders were involved in the PR campaign that eventually led to Biden's Admin mandates. This explosive revelation is both shocking and infuriating how so-called Christians colluded with Fauci's NIH.RumbleSee omnystudio.com/listener for privacy information.

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Advice on communicating in and around the biosecurity policy community, published by Elika on March 2, 2023 on The Effective Altruism Forum. TL;DR The field of biosecurity is more complicated, sensitive and nuanced, especially in the policy space, than what impressions you might get based on publicly available information. As a result, say / write / do things with caution (especially if you are a non-technical person or more junior, or talking to a new (non-EA) expert). This might help make more headway on safer biosecurity policy. Generally, take caution in what you say and how you present yourself, because it does impact how much you are trusted, whether or not you are invited back to the conversation, and thus the potential to make an impact in this (highly sensitive) space. Why Am I Saying This? An important note: I don't represent the views of the NIH, HHS, or the U.S. government and these are my personal opinions. This is me engaging outside of my professional capacity to provide advice for people interested in working on biosecurity policy. I work for a U.S. government agency on projects related to oversight and ethics over dual-use research of concern (DURC) and enhanced pandemic potential pathogens (ePPP). In my job, I talk and interface with science policy advisors, policy makers, regulators, (health) security professionals, scientists who do DURC / ePPP research, biosafety professionals, ethicists, and more. Everyone has a slightly different opinion and risk categorisation of biosecurity / biosafety as a whole, and DURC and ePPP research risk in specific. As a result of my work, I regularly (and happily) speak to newer and more junior EAs to give them advice on entering the biosecurity space. I've noticed a few common mistakes with how many EA community members – both newer bio people and non-bio people who know the basics about the cause area – approach communication, stakeholder engagement, and conversation around biosecurity, especially when engaging with non-EA-aligned stakeholders whose perspectives might be (and very often) are different than the typical EA-perspective on biosecurity and biorisk. I've also made many of these mistakes! I'm hoping this is educational and helpful and not shaming or off-putting. I'm happy to help anyone unsure communicate and engage more strategically in this space. Some Key Points that you might need to Update On. Junior EAs and people new to biosecurity / biosafety may not know how to or that they should be diplomatic. EA communities have a trend of encouraging provoking behaviour and absolutist, black-and-white scenarios in ways that don't communicate an understanding of how grey this field is and the importance of cooperation and diplomacy. If possible, even in EA contexts, train your default to be (at least a bit more) agreeable (especially at first). Be careful with the terms you use and what you say Terms matter. They signal where you are on the spectrum of ‘how dangerous X research type is', what educational background you have and whose articles / what sources you read, and how much you know on this topic. Example: If you use the term gain-of-function with a virologist, most will respond saying most biomedical research is either a gain or loss of function and isn't inherently risky. In an age where many virologists feel like health security professionals want to take away their jobs, saying gain-of-function is an easy and unknowing way to discredit yourself. Biosafety, biorisk, and biosecurity all indicate different approaches to a problem and often, different perspectives on risk and reasonable solutions. What terms you use signal not only what ‘side' you represent, but in a field that's heavily political and sensitive can discredit you amongst the other sides. Recognise how little (or how much) you know Biosec...

Senator Tom Cotton of Arkansas, talks about the now confirmed lab leak and what it means for those individuals who lied in the NIH and CDC to the American people and under oath to Congress. See omnystudio.com/listener for privacy information.

The Department of Energy just released a bombshell new report that states it believes the lab leak theory is the most likely origin of the COVID-19 virus. This makes them the second federal agency to come to this conclusion, while gain-of-function research carries on and Ecohealth Alliance, the nonprofit Fauci's NIH used as a pass-through organization to fund the Wuhan lab, continues to receive millions of dollars.     Jack Hunter steps in for Brad on this episode and discusses the mainstream media's desperate attempts to spin this report online.     Then, Hannah and Jack dissect the two Supreme Court cases being heard this week that challenge the Biden Administration's plans to cancel student debt. Hannah details how this decision could have a major ripple effect across various government agencies, and then the two turn their attention to the third party payments swirling between medical companies like Pfizer and the NIH.     Next, in their quick hits segment, Hannah and Jack react to a viral video where a flight passenger demands another person give up his seat so that he can sit by his wife, a Tik Tok that claims pretty women are bullied more, and finally, a hilariously hypocritical healthcare take. They round out the show by reading your thoughts from the comment section and offering hot takes.     Like the podcast? Support us on Locals to show your support and connect with us directly: https://basedpolitics.locals.com/     Want to join us at FreedomFest? Head to https://www.freedomfest.com/rates/ and use promo code "BASEDPolitics50."

In Florida, medical freedom activists are putting more and more pressure on a certain hospital system located in the city of Sarasota. This particular hospital put out an official report that touted how awesome their response to COVID-19 was. However, these medical freedom activists, which include people who lost family members to COVID-19 at this hospital, are calling this report a “cover-up.” They accused the hospital system of using ineffective treatments just because those treatments were directly tied to federal payouts from the CDC and NIH. Several people blamed the use of the drug remdesivir for the deaths of their family members, while several others described the process of begging the hospital to consider using alternative treatments. Moreover, on the same day that this report was released, the hospital hosted a board meeting wherein hundreds of people from across the state came in to hear what the hospital would say about their treatments—which many people allege actually led to unnecessary deaths. However, it appears that the hospital management knew that a large crowd was coming to the event, and so they padded the audience with their own employees, who did nothing but sing praises for the treatment. ⭕️ Sign up for our NEWSLETTER and stay in touch

In this episode, we interview two guests, Dr. Guadalupe Garcia Tsao and Dr. Andrew Yu. Dr. Yu is the Emory transplant Hepatology fellow currently. We discuss the Baveno VII guidelines on Portal Hypertension and some major takeaways from #TLM or the American Association for the Study of Liver Diseases (AASLD) meeting in Washington D.C.  Dr. Guadalupe Garcia Tsao is a Professor of Medicine at Yale University School of Medicine and Chief of Digestive Diseases at the VA-Connecticut Healthcare System. She also serves as director of the Clinical Core of the NIH-funded Yale Liver Center and is the Associate Editor of the New England Journal of Medicine. She was president of AASLD in 2012.   FIB4+ Scoring Algorithm - http://fib4plus.com/ Host: Dr. Chuma Obineme (GI Fellow) –  https://twitter.com/TypicallySilent    Co-Host: Jason Brown - https://med.emory.edu/directory/profile/?u=JMBROW2    Guest: Guadalupe Garcia-Tsao - https://twitter.com/ggarciatsao https://medicine.yale.edu/profile/guadalupe-garcia-tsao/   Guest: Andrew Yu - https://twitter.com/michaelandrewyu   Link to Review: https://www.sciencedirect.com/science/article/pii/S0168827821022996   Link to Emorid Digest visual Summary: https://med.emory.edu/departments/medicine/_documents/yu-preventing-decompensation-in-cirrhosis-tips-from-baveno-vii.pdf   Link to Emoroid Digest Website: https://med.emory.edu/departments/medicine/divisions/digestive-diseases/education/emoroid-digest.html  

Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment in new pain and addiction treatments is falling short of what is needed, according to a new BIO report, which shows a 44% decrease in clinical drug programs for pain over the past five years. Our guests on this episode talk about the challenges of living with and treating pain, as well as research and development on new, non-addictive and safer pain therapies. 

In this episode, Drs. Temara Hajjat and Jason Silverman talk to Dr. Miranda van Tilburg about the behavioral treatment of functional abdominal pain. We discuss issues of pain perception, pain coping and maladaptive responses to pain. We also discuss some research-informed behavioral interventions to help treat children with FAP.Dr. van Tilburg needs is a psychologist and researcher who has worked extensively on the behavioural explanations for and treatment of functional GI disorders, including work supported by the NIH and the Rome Foundation. She is currently a Professor in the Department of Medicine at Marshall Health in Huntington, WV and was recently named Chair of the Ethics Committee at NASPGHAN. This episode is eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!Learning Objectives:Understand the relationship of pain perception and pain coping to symptoms experienced by children with functional abdominal pain. Understand the importance of an appropriate framework to explain functional abdominal pain to children and their parents in a way that validates their experiences.Name 3 possible behavioral treatment options that may be useful in children with FAP.Produced by: Jason SilvermanSupport the showAs always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Follow us on Twitter, Facebook and Instagram for all the latest news and upcoming episodes!

On today's episode, Woody Allen shocks the world on SNL and takes a massive shot at Big Pharma and Fauci. Also, the covid lab leak theory (that we got canceled and demonetized for) is now being back by the US Energy Department?!! Fauci's back in the news, as word's come out that he and the NIH received massive royalties from Pharma companies?! ► Today's Sponsors: Protect your savings with the precious metal IRA specialist. www.birchgold.com Text: Graham to 989898 Drink America's coffee at www.blackriflecoffee.com/ Protect you family and leave a legacy with Epic Will: www.epicwill.com/graham ► Connect with us: Merch: www.officialgrahamallen.com Support us as we advocate for freedom: www.grahamallen.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Can A Whole Food Plant Based Diet Prevent, Suspend, And/Or Cure Many Chronic Diseases? T. Colin Campbell, PhD• https://nutritionstudies.org/ • Book - China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long Term Health #TColinCampbell#ChinaStudy #PlantBased #WoleFoodDiet T. Colin Campbell, PhD has been dedicated to the science of human health for more than 60 years. His primary focus is on the association between diet and disease, particularly cancer. Although largely known for the China Study — one of the most comprehensive studies of health and nutrition ever conducted, and recognized by The New York Times as the “Grand Prix of epidemiology” — Dr. Campbell's profound impact also includes extensive involvement in education, public policy, and laboratory research. Dr. Campbell grew up on a dairy farm and was the first in his family to go to college, where he studied pre-veterinary medicine at Pennsylvania State University. After obtaining his bachelor's degree, and while completing his first year at the University of Georgia veterinary school, he received a telegram from a well known professor at Cornell University, offering a scholarship and research opportunity too good to turn down. And so he completed his education at Cornell University (M.S., Ph.D.) and MIT (Research Associate) in nutrition, biochemistry and toxicology. He then spent 10 years on the faculty of Virginia Tech's Department of Biochemistry and Nutrition before returning to Cornell in 1975 where he presently holds his Endowed Chair as the Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry in the Division of Nutritional Sciences. Dr. Campbell's research experience includes both laboratory experiments and large-scale human studies. He has received over 70 grant-years of peer-reviewed research funding (mostly with NIH), served on grant review panels of multiple funding agencies, actively participated in the development of national and international nutrition policy, and authored over 300 research papers. Throughout his career, he has confronted a great deal of confusion surrounding nutrition and its effects. It is precisely this confusion that he has focused so much on, in recent years. In order to synthesize the findings of his long and rewarding career, and to give back to the public whose lives are threatened by rampant misinformation and special interests, Dr. Campbell co-wrote The China Study: Startling Implications for Diet, Weight Loss and Long-term Health, which has sold more than 2 million copies worldwide. He is also the author of the The New York Times bestseller Whole, and The Low-Carb Fraud. Several documentary films feature Dr. Campbell and his research, including Forks Over Knives, Eating You Alive, Food Matters, and PlantPure Nation. He continues to share evidence-based information on health and nutrition whenever given the opportunity. He has delivered hundreds of lectures around the world and he is the founder of the T. Colin Campbell Center for Nutrition Studies and the online Plant-Based Nutrition Certificate in partnership with eCornell. To Contact Dr. T. Colin Campbell, Ph.D.  go to nutritionstudies.org Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

This week week look at a piece by David Katz: "I imagine -and in select cases know- that many of my colleagues were encouraged and gratified to hear that the NIH is allocating a sizable sum to the pursuit of precision nutrition. Some number of my colleagues will be directly involved in those research efforts, and others are simply pleased to see nutrition getting some small measure of the attention we agree it warrants. I can appreciate these reactions, but in my case, the response felt more like a wave of nausea accompanied by echoes of “here we go again, again.....” We also look at some recent studies in the aging space. Two studies by Dr. Sinclair and Dr. Macip looking at age reversal ability. From the David Sinclair Lab at Harvard we see first of its kind data regarding the ability to identify epigenetic marks in mice as the etiology or biomarker of aging. This is nothing short of an amazing discovery. Listen to Podcast #2 with the father of epigenetics Dr. Randy Jirtle to gain a foothold in this world and then listen on. Enjoy, Dr. M

Welcome to the 2 View - Episode 24 Welcome to Episode 24 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 24 of “The 2 View” – New street drug xylazine/"tranq," app for EM coding changes, FPL injuries, hemorrhoids. Molnupiravir Butler CC, Hobbs FDR, Gbinigie OA, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet. PubMed. NIH: National Library of Medicine, National Center for Biotechnology Information. Published January 28, 2023. Accessed February 21, 2023. https://pubmed.ncbi.nlm.nih.gov/36566761/ Molnupiravir. COVID-19 Treatment Guidelines. NIH. Last Updated: September 26, 2022. Accessed February 21, 2023. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/molnupiravir/ Easy Emergency Medicine Coding Calculator American Medical Association. 2023 Emergency Medicine Coding Guide. MDCalc. Accessed February 21, 2023. https://www.mdcalc.com/calc/10454/2023-emergency-medicine-coding-guide CPT Evaluation and Management (E/M) Code and Guideline Changes. Ama-assn.org. AMA: American Medical Association. Accessed February 21, 2023. https://www.ama-assn.org/system/files/2023-e-m-descriptors-guidelines.pdf Graham. 2023 Emergency Medicine Level of Service/Billing Guidelines Overview. Published December 31, 2022. Accessed February 21, 2023. https://www.youtube.com/watch?v=WuV8O3SuXJI The Center for Medical Education. Documentation Changes that Can Help Your Practice. Published August 16, 2022. Accessed February 21, 2023. https://www.youtube.com/watch?v=gHLBjzQt4vo Xylazine DEA Joint Intelligence Report. The Growing Threat of Xylazine and its Mixture with Illicit Drugs. U.S. Department of Justice Drug Enforcement Administration. Dea.gov. Published October 2022. Accessed February 21, 2023. https://www.dea.gov/sites/default/files/2022-12/The%20Growing%20Threat%20of%20Xylazine%20and%20its%20Mixture%20with%20Illic it%20Drugs.pdf FDA warns about the risk of xylazine exposure in humans. Fda.gov. FDA. Published November 8, 2022. Accessed February 21, 2023. https://www.fda.gov/media/162981/download Hoffman J. Tranq dope: Animal Sedative Mixed with Fentanyl Brings Fresh Horror to U.S. Drug Zones. The New York Times. Published January 7, 2023. Accessed February 21, 2023. https://www.nytimes.com/2023/01/07/health/fentanyl-xylazine-drug.html. National Institute on Drug Abuse. Xylazine. National Institute on Drug Abuse: Advancing Addiction Science. Published April 21, 2022. Accessed February 21, 2023. https://nida.nih.gov/research-topics/xylazine Overdose C on O. Toxicity of Xylazine and How It Impacts People Who Use Drugs by Dr. Joseph D'Orazio. Published June 15, 2022. Accessed February 21, 2023. https://www.youtube.com/watch?v=Rqpf0jIuyCo Flexor Pollicis Longus and Other Thumb Injuries Gault D. A review of repaired flexor tendons. J Hand Surg Br. ScienceDirect. Published October 1987. Accessed February 21, 2023. https://www.sciencedirect.com/science/article/abs/pii/0266768187901811 Urbaniak JR. Repair of the flexor pollicis longus. Hand Clin. Europe PMC. Published February 1, 1985. Accessed February 21, 2023. https://europepmc.org/article/med/3912396 Hemorrhoids Procedure Review: Thrombosed Hemorrhoids. EM:RAP. EM:RAP.ORG. Published April 2018. Accessed February 21, 2023. https://www.emrap.org/episode/emrapliveapril/procedurereview Zuber TJ. Hemorrhoidectomy for Thrombosed External Hemorrhoids. Am Fam Physician. AAFP. Published 2002. Accessed February 21, 2023. https://www.aafp.org/pubs/afp/issues/2002/0415/p1629.html Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share!

One of the most difficult concepts to master as a runner is that you don't need to be running faster, longer or harder every time out to improve.  In fact, sometimes running just below or slower than your potential in workouts leads to more consistent improvement. In this week's episode, Coach Jeff is going to discuss the science about why this is so you can fully understand the concept and apply it to your running.  Download the Visual Guide  Connect, Comment, Community Follow RunnersConnect on Instagram Join the Elite Treatment where you get first dibs on everything RTTT each month! Runners Connect Winner's Circle Facebook Community  RunnersConnect Facebook page GET EXPERT COACHING AT RUNNERSCONNECT! This week's show brought to you by: Mobility Wall We all know how important foam rolling is for staying injury-free and just plain feeling better for every run. But, let's face it, many of us skip it because clearing out space on the floor feels like too much work, the pressure is too painful and difficult to control, or you can't seem to hit the right spots. That's why I was so amazed when I saw the door-mounted foam roller from Mobility Wall.  The Mobility Wall device mounts to your doorframe in just a few seconds and is easy to move up and down the frame in just a few seconds.  Not only does this get you off the ground and ready to foam roll in just a few seconds, it also allows you to easily hit muscles in your neck and shoulders that aren't possible with a traditional foam roller.  Even better, because you're off the ground, you don't have to control gravity to adjust the pressure. You simply use upward and inward pressure, which is much easier to control. The days of painful foam rolling are over.  If you've been wanting to get more consistent with your injury-prevention work this year, the Mobility Wall foam roller will be a game changer. I can't believe how much more I've been foam rolling since I started using it.  Plus, we've got a special offer for you. Just go to mobilitywall.com/RTTT or enter RTTT at checkout for 20% off your first order. Plus, it comes with a free app that gives you video instructions on exactly how to hit every area.  Delta G Ketones have been one of the most well-researched chemicals when it comes to endurance performance. Their only downside is that it typically takes 2 days of fasting for your body to produce them in quantities that would help your performance But, thanks to deltaG and collaborations from the US Military and researchers from NIH and the University of Oxford, they've developed a ketone drink that can boost your ketone levels to those seen after 2 days of fasting in just 20 minutes.  The academic literature on the effectiveness of ketones for running performance is overwhelming. If you want to see more of the research, head to runnersconnect.net/deltag Plus, use the code RTT20 when you do and you can save 20% on any purchase you make.

~ Co-presented by The New School at Commonweal and the Collaborative for Health and Environment ~ The harm to human health from chemical exposures is now recognized as a global crisis on par with climate change and biodiversity loss. Effectively addressing this challenge means adopting new approaches that recognize the complexity of systems with multi-disciplinary approaches, prioritize precaution and prevention, and address disproportionate impacts and environmental injustices. Join Host Steve Heilig for a conversation with Dr. Linda Birnbaum and Dr. Ami Zota, two innovative leaders in efforts to promote environmental health and justice in the United States. Dr. Linda Birnbaum Linda is the former Director of the National Institute of Environmental Health Sciences and the National Toxicology Program. She was granted Scientist Emeritus Status at NIH when she retired and is also a Scholar in Residence at the Nicholas School of the Environment, Duke University. As NIEHS director, Dr. Birnbaum oversaw research grants and shared the results of cutting edge environmental health research with the public and policy makers. She also met with communities to better understand environmental health concerns and disparities. Throughout her career, Dr. Birnbaum has been particularly effective at bringing forward the mounting scientific evidence of harm of exposures to certain chemicals that are now ubiquitous in our products and environment. Her discussion of the current science has helped to shift our understanding of exposures to include the dangers of chronic low dose exposures and the long term effects of early lifetime exposures. Dr. Ami Zota Ami is a population health scientist with expertise in environmental health, environmental justice, and maternal and reproductive health. Her research focuses on understanding social and structural determinants of environmental exposures and their consequent impacts to women's health outcomes across the life course. Her long-term goal is to help secure environmental justice and health equity among systematically marginalized populations by advancing scientific inquiry, training next generation leaders, increasing public engagement with science, and supporting community-led solutions for structural change. Dr. Zota is the founding director of the Agents of Change in Environmental Justice program which seeks to foster more diverse, equitable and inclusive leaders in environmental and climate justice, training early career scientists from systematically marginalized backgrounds in science communication, storytelling, community engagement, and policy translation. Dr. Zota received CHE's “20 Pioneers Under 40 in Environmental Public Health” award in 2018. Host Steve Heilig Steve is a longtime senior research associate with Commonweal, a co-founder of the Commonweal Collaborative for Health and Environment, a host of dialogues for the New School, and in other programs originating at or founded at Commonweal. Trained at five University of California campuses in public health, medical ethics, addiction medicine, economics, environmental sciences, and other disciplines, his other work includes positions at the San Francisco Medical Society, California Pacific Medical Center, and as co-editor of the Cambridge Quarterly of Healthcare Ethics. He has served on many nonprofit boards and appointed commissions, and is a trained hospice worker. He is a widely published essayist and book and music critic for the San Francisco Chronicle, Huffington Post, and many other publications. Find out more about The New School at Commonweal on our website: tns.commonweal.org. And like/follow our YouTube and Soundcloud channels for more great podcasts.

When treating cancer patients, physicians are often faced with tough choices.  Treatment options like radiation can often come with unpleasant, for some, unbearable side-effects. Doctors walk a fine line between stopping the growth of cancer cells and giving cancer cells the very thing they need to grow and spread.     City of Hope and TGen physician-scientist Yun Rose Li, M.D., Ph.D., has been called trailblazing and innovative by the NIH in her research into oxidative stress and its effects on cancer cells. Dr. Li is using a five year, nearly $2 million grant to study how manipulating oxidative stress can improve the outcomes of her patients with genitourinary cancers.     Recruited for her research while still a resident at UC San Francisco, Dr. Li is quickly proving it no longer takes a lifetime in cancer research to make a difference in the lives of patients.

We love data sharing around here, and something exciting happened In January 2023: The NIH put into effect a brand new Data Management and Data Sharing Policy. Any grant submitted to the NIH must follow this new Policy, and each grant submitted will include a Data Management and Sharing Plan describing how the research team will comply with that policy. Have a listen as Jess and Sara describe the new Policy, and walk you through the parts of the Plan, with honestly a bit more enthusiasm than should be allowed for reading and discussing a Policy. We talked about: The NIH Website about their new Data Management and Sharing Policy. How to budget for Data Management and Sharing in a grant application. The decision tool - to figure out which Policies apply to you. About selecting a data repository - remember, always choose a domain-specific repository when you can! The Sample Data Management and Sharing Plans for different institutes. The template for their Data Management and Sharing Plan (this will download as a document!). Connect with the podcast on twitter @within_between, or email us letters about developmental science at withinandbetweenpod@gmail.com. More episodes and podcast information at WithinandBetweenPod.com. Follow Dr. Hart on twitter @Saraannhart Follow Dr. Logan on twitter @Jarlogan. Our theme music was composed by Jason Flowers. Our logo was created by Nathan Archer.

McCarthy promised to release ALL of the J6 footage, but a week later, that promise was broken. Instead, McCarthy gave it all to Tucker Carlson for him to gatekeep. The American people DESERVE to see every bit of the footage from j6. Despite this, Tucker has said that he and his team will only release highlights. We are almost three weeks away from the Ohio train derailment, but the nightmare is no where near over for the residents of East Palestine. The people there are still left in the dark, and suffering. There was clean up, but that was only to get trains running again. Candice went to the hospital for chemical burns, despite the EPA insisting that everything is "fine." Our government needs to DO SOMETHING. Please support Candice here: https://www.givesendgo.com/G9U19 The CDC was shot down and denied bioweapon funding! Karen Kingston joins Stew to share how her work in Collier County Florida PROVED that Pfizer produced bioweapon injections with the help of the government! Through presenting her evidence and sharing a powerful testimony, Karen was able to convince Commissioner Chris Hall to stop the $1.4 million in NIH funding to the CDC! Don't let the worries of the world keep YOU sleepless and unrested! Try premium sleep supplements to feel renewed by visiting: https://sleepbreakthrough.com/stewpeters Proper sleep is the root to a healthy lifestyle, but it's increasingly difficult to maintain! Wade Lightheart joins guest host Paul Harrell to detail the importance of sleep, and how it transforms your life! Watch this new show NOW at Stewpeters.com! Keep us FREE and ON THE AIR! SUPPORT THE SPONSORS Below! From spy balloons to saber rattling, does China hold a deadly secret that would cripple our country beyond recognition? America's biggest threat in 2023. This documentary https://darkagedefense.com/stewpeters exposes the truth!! Taxation is THEFT! Never again voluntarily pay the Washington D.C. Swamp, legally and safely, GUARANTEED when you attend Freedom Law School! Visit: https://FreedomLawSchool.org Protect your retirement, Visit our friends at Goldco! Call 855-706-GOLD or visit https://goldco.com/stew Clean up your AIR with these high quality air filtration systems, and protect yourself from shedding: https://thetriadaer.com/ Support anti-vax activism, free clinic care, and MANLY products like IGF1 visit:https://Vaccine-Police.com Check out https://nootopia.com/StewPeters for help increasing your mental & physical strength to battle the deep-state's KRYPTONITE plot against Americans! Get the best sleep you've ever had with this high quality, non drowsy sleep supplement: https://sleepbreakthrough.com/stewpeters  STEWPETERS10 at checkout for 10% off your order. Check out: https://kuribl.com/ STEW20 for 20% off your order or premium CBD! Prepare your family for famine and shortages by purchasing food through: https://heavensharvest.com/ LOSE WEIGHT, and CLEAN OUT your GUT: https://www2.gutcleanseprotocol.com/cid/7013w000002HTxJAAW Go Ad-Free, Get Exclusive Content, Become a Premium user: https://www.stewpeters.com/subscribe/ Follow Stew on Gab: https://gab.com/RealStewPeters See all of Stew's content at https://StewPeters.com Check out Stew's store: https://stewmerch.com

As women, there is no shortage of things that we worry about. But we're no good to others if we're not at the top of the list.  On the podcast, I talk a lot about being in a good mental space, but our physical health is just as important.  In this episode, I'm talking to Dr. Nicole Farmer, NIH physician scientist and internal medicine doctor, about women's health and how we can ensure we're health-conscious. And because she's a researcher, I ask her about the importance of medical research, and how history prevents Black Americans from fully benefiting from clinical advancements. About My Guest:Dr. Nicole Farmer is currently a Physician Scientist at the NIH Clinical Center and the Acting Section Chief of the Dietary Behaviors and Biopsychosocial Health Section. Dr. Farmer is involved in both community-based and patient research exploring the role of cooking in chronic disease prevention and psychosocial health. Prior to joining the NIH, she was a well-established primary care clinician and routinely engaged her patients in nutrition education through cooking classes. Dr. Farmer is an alumnus of Howard University College of Medicine, received her internal medicine training from Thomas Jefferson University Hospital, and held a prior appointment at Johns Hopkins University Hospital. She has also completed fellowship training in Integrative Medicine from University of Arizona and Duke University. In addition, Dr. Farmer was named a Harvard Macy Fellow in 2021 for her work on incorporating humanities into culinary medicine education and research. Grown and Growing Podcast: Like. Follow. Share. Connect with me:Website: grownandgrowing.buzzsprout.comFacebook: @GrownandgrowingpodcastInstagram: @GrownandgrowingpodcastEmail: grown.growingpodcast@gmail.com

Is it time to talk about Pre-Addiction? We have pre-diabetes and pre-glaucoma, diagnosis intended to prompt early treatment in order to prevent worse disease.  Should we be diagnosing and treating Pre-Addiction? Thomas McLellan, Ph.D. has been a career researcher in addiction treatment and policy for 40 years, working primarily at the University of Pennsylvania and at the Treatment Research Institute (TRI) which founded and served as CEO for 25 years. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment.  From 2009 to 2011, he was Deputy Director of the White House Office of National Drug Control Policy (ONDCP) where he formulated President Obama's National Drug Control Strategy and helped include addiction treatment into the Affordable Care Act.  In 2015-2016 he served as Senior Editor on the US Surgeon General's Report, Facing Addiction. In his career he has published over 550 articles and chapters on addiction research and was awarded over 150 NIH research grants.  He has been among the top ten most cited researchers in the addiction field for 15 years. Dr. McLellan is the recipient of several distinguished awards including the Lifetime Achievement Awards of the American, Italian, Australian, Egyptian and British Societies of Addiction Medicine; the Robert Wood Johnson Innovator Award; Distinguished Contribution to Addiction Medicine from the American Public Health Association, the American Medical Association; and jointly from the National Institutes of Drug Abuse and Alcoholism and Alcohol Abuse. He currently serves on the boards of Indivior LLC (makers of Suboxone) and Recover Together; and lives with his wife Kerry in Sarasota Florida. Pre-Addiction - A Missing Concept for Treating Substance Use Disorder, Aug 2022

Vi har besøk av Torkil Færø, kanskje best kjent som «pulslegen» i disse dager og aktuell med boken Pulskuren. Han har satt begrepet pulsvariabilitet, HRV, på agendaen, og mener det er ikke bare en random verdi på pulsklokka men et styringsverktøy og måleparameter som gir oss verdifull informasjon om stressnivåer, søvnkvalitet, generell form og restitusjonsbehov etter økter, for å nevne noe. Vi møter Torkil for en åpen prat, og prøver, i tillegg til det overnevnte, å bli kloke på om dette rett og slett kan bli for mye av det gode - skal vi heller lytte til klokka og dens verdier enn vår egen kropp..? Vi har med oss Melina Magulas i deler av episoden, fysiolog på NIH, som deler verdifulle perspektiver. Vi håper du ser på episoden som et lærerikt innslag om nettopp HRV, og at det hjelper deg til å avgjøre om dette er noe du føler din hverdag trenger eller ikke. Hjelper det deg til å kontrollere stresset eller skaper det mer stress? Det kan kun du selv avgjøre. God lytt! Hosted on Acast. See acast.com/privacy for more information.

Today, I interview independent reporter Jimmy Tobias. Jimmy successfully challenged the NIH to have the redactions removed from Dr Fauci's emails surrounding his secret deliberations with NIH Director Francis Collins, Jeremy Farrar, and several renown virologists regarding the possible lab origin of COVID-19. We discuss the content of those unredacted emails between Drs. Fauci, Collins, Farrar and a cabal of internationally recognized virologists in the first nine days of February 2020.  These emails followed the now notorious February 1st, 2020, secret teleconference arranged by Jeremy Farrar and Anthony Fauci to discuss the unanimous opinion of four renown virologists that the virus responsible for the COVID-19 pandemic had genetic features that looked “potentially engineered” and was “inconsistent with expectations from evolutionary theory.” Within days of that secret teleconference, these virologists made a 180-degree about-face and wrote a highly influential correspondence in Nature Medicine entitled: The Proximal Origin of SARS-CoV-2 stating unequivocally that the virus responsible for the COVID-19 could not have come from a lab. How the authors of The Proximal Origin Correspondence came to this reversal so quickly and so adamantly without any credible science to justify it was a mystery... until the redactions from Fauci emails were removed.

Our guest for this episode is Dr. Howard Rankin, who has has extensive expertise and knowledge in the areas of psychology, neuroscience, behavior change and neurotechnology. He has worked extensively in the addictions space, running both inpatient and outpatient programs. Along with a career in academics and research, he is also an experienced speaker, coach and best-selling and award-winning author. Dr. Rankin has written 12 books in his own name, co-written another 12, and ghostwritten 30 others, all nonfiction. Howard has also published more than 30 scientific articles on addiction and behavior change, and been a consultant to the NIH and WHO. His latest books include I Think Therefore I Am Wrong: A Guide to Bias, Political Correctness, Fake News and the Future of Mankind which explores the default setting of the mind and how that can lead us astray, Falling to Grace: The Art and Science of Redemption was released on April 15, 2022 and was featured in Psychology Today magazine (May 2022 issue).  Dr. Rankin is also a Psychology Today blogger, the creator and host of the How Not To Think podcast and a consultant to Sapien Labs and Science Director at IntualityAI. https://www.drhowardjrankin.com/ Join us at NEURO Academy, a membership based online environment where you'll have access to resources to achieve optimal health, a better, sharper memory, and prevent cognitive decline. The platform provides the opportunity to connect with us and an empowering community and participate in weekly live Q&A sessions, live cooking sessions, live podcasts and Q&A with remarkable health leaders, have access to on demand courses on prevention of neurological diseases, expanding the course to evidence based nutrition and cooking,  anxiety, and many others on various topics related to brain health. We just released a comprehensive course of evidence based nutrition in  brain health, along with a complete cooking course that will help you learn the basics of healthy eating and how you can apply all the knowledge by improving what's on your plate. You will be able to get CE or CME credits if you're interested, and also receive certification after taking the course. If you join today and until Feb 28th, you will have a chance to get three months off!  Join the NEURO Academy: https://neuroacademy.com/ Follow us: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: https://thebraindocs.com/

When National Institutes of Health (NIH) Director Francis Collins finally retired last year, we warned that nothing would change. We said the same thing when Dr. Anthony Fauci retired on Dec. 31, 2022. That turned out to be correct, as everyone was able to see last week when new NIH Director Lawrence Tabak was trotted out for a congressional hearing. Tabak repeated the exact same lies that Collins and Fauci pushed in the past. And the Republicans asking him questions were just as hopeless at cornering Tabak as they were at cornering the old guard. Tabak is deeply entangled in the Wuhan lab leak coverup as well as in the deletion of crucial Chinese sequence data from the NIH's database. But you wouldn't know this from listening to the hearings. We'll tell you the real story, the one neither the corporate media nor Republican House members cared to tell. ⭕️ Watch in-depth videos based on Truth & Tradition at Epoch TV

In this episode we will discuss Lewy Body Dementia compared to Parkinson's dementia. It can by very hard to distinguish between the two, so pay close attention. Also, here is a link to learn more about LBD from the NIH: https://www.nia.nih.gov/health/what-lewy-body-dementia-causes-symptoms-and-treatments Please support this podcast and our endeavors by becoming a co-producer of the show! Sign up as a Patreon supporter here at https://www.patreon.com/pdwarriors Also, you can leave a one time tip in our virtual tip jar at: https://paypal.me/hylandptw Don't forget about our YouTube channel!!

Ozempic. Wegovy. Rybelsus. These brand names of the medication semaglutide (a GLP-1) have recently been having quite the moment in the spotlight. From social media influencers and celebrities to publications and news outlets, it seems everyone has been talking about this “miracle drug.” Following increased exposure and curiosity among the general population about semaglutide, there's been an influx of non-science-backed headlines and misinformation spread across the internet. Any time a new medication enters the market, evidence-based education is crucial for consumers to understand what these medications can and cannot do. Many people are searching for the elusive quick fix, but does it actually exist? What are the implications, and how do nutrition and lifestyle factors come into play? As part of our commitment to educating our community, we're shedding light on this very relevant and timely topic in the latest episode of Stronger U Radio. Manager of Nutrition Content and Innovation Gianna Masi, RD, sat down with NIH-funded principal investigator and board-certified primary care nurse practitioner Dr. Tina Sadarangani, Ph.D. to debunk the myths and set the record straight (based on fact, not fiction) around semaglutide and weight loss. Dr. Tina has an impressive background and brings a wealth of experience in the medical field. She's also an assistant professor in the NYU Grossman School of Medicine's Department of Population Health. Her research program is underscored by a profound commitment to advancing the health of minoritized populations and targeting health disparities. Tune into this evidence-based conversation for answers to many of the most common questions, such as: What is semaglutide?How does it work?How can it help with weight loss?Who is a candidate?What are the pros and cons?What are the common side effects?How much does it cost?What are some important considerations?How can you support your long-term health in conjunction with these drugs?Plus, Dr. Tina and Gianna chat about medication accessibility, the many factors that can contribute to weight gain, and why these medications are part of a broader toolbox.    Listen to the full episode and then head to the Stronger U Community to share your thoughts and takeaways.   Subscribe to Stronger U Radio  Follow us on Instagram 

On this episode of Inside Health Care, we offer two interviews. NYC Health + Hospitals leaders, Dr. Eric Wei and Dr. Ted Long, discuss hospital worker burnout, including suicide, and the need for awareness, mitigation and prevention. After that, Inland Empire Health Plan Chief Quality Officer, Dr. Edward Juhn, talks about “algorithmic bias,” a software-based anomaly that may adversely affect population health metrics that drive research on equity. Both interviews were recorded live at NCQA's inaugural Health Innovation Summit, held in late 2022 in Washington, DC. Later, in our “Fast Facts” segment, we observe American Heart Month, with hints for keeping your heart healthy from NIH's National Heart, Lung and Blood Institute. We also tell you about an NCQA HEDIS measure, Cardiac Rehabilitation, that assesses the percentage of adults 18 and older who attended cardiac rehab after a cardiac event like a heart attack, heart transplant or heart bypass.

Dr. Paul Alexander Liberty Hour – The CDC, NIH, FDA, Pfizer, Moderna, and other policymakers know that the vaccine does not sterilize the virus (stop infection, replication, transmission) and is ineffective with negative effectiveness, and also deadly. They know this. This is the hill parents must be willing to defend, with their lives if need be. No shot for your healthy child!